{
  "id": "5c8cfca70101eac870000005",
  "type": "yesno",
  "question": "Has the protein SIRT2 been associated to cervical cancer?",
  "ideal_answer": "Yes.\nA progressive increase in the expression of both SIRT2 and SIRT7 was noted during cancer progression in the following order: normal\u2009<\u2009preneoplasia\u2009<\u2009cancer.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25794641",
    "http://www.ncbi.nlm.nih.gov/pubmed/28776959"
  ],
  "snippets": [
    {
      "text": " A progressive increase in the expression of both SIRT2 and SIRT7 was noted during cancer progression in the following order: normal\u2009<\u2009preneoplasia\u2009<\u2009cancer.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794641",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " We demonstrate that treatment of cervical cancer cells with a RhoGDI\u03b1-derived K52-trifluoroacetylated, substrate-derived peptidic sirtuin inhibitor severely impairs cell proliferation. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28776959",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}